Biocon Shares Rally On Strong Q1 Numbers

Subscribe to GoodReturns
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

    Shares of the Biocon rose more than 3 per cent on Friday after the company reported strong set of Q1 numbers.

    Biocon Ltd on Thursday reported 23 per cent growth in consolidated net profit at Rs 126 crore for the quarter ended June 30, 2015, against Rs 103 crore in the same quarter of previous year.

    Check the share price details and financials of the company.

    Biocon Shares Rally On Strong Q1 Numbers
    Biocon: Quotes, News
    BSE 624.35BSE Quote1.95 (-0.31%)
    NSE 624.95NSE Quote1.2 (-0.19%)
     

    The company's total income rose 15 per cent to Rs 857 Crore against from Rs 742 crore for the quarter ended June 30, 2014 .

    "Our biosimilars strategy is playing out well with five programmes in phase 3 clinical development," Biocon chairman and managing director Kiran Mazumdar-Shaw said in a press statement. 

    During the quarter we successfully licensed biosimilar Trastuzumab in key emerging markets. Our Insulins business was boosted with the launch of insulin Glargine in Mexico and Colombia. Our focus on key brands in Branded Formulations has begun to translate into a better quality of earnings, addded further.

    The company said that it has appointed Narendra Chirmule as the Head of R&D. The Insulins Drug Products facility in Malaysia successfully completed a cGMP audit by Malaysia's National Pharmaceutical Control Bureau (NPCB).

    Recently, Syngene International, research arm of biotechnology major received Securities Exchange Board of India's (Sebi) approval to launch an initial public offer (IPO).

    GoodReturns.in

    Read more about: biocon
    Story first published: Friday, July 24, 2015, 9:51 [IST]
    Company Search
    Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

    Find IFSC

    Get Latest News alerts from Goodreturns

    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more